- Previous Close
113.00 - Open
124.60 - Bid 116.70 x --
- Ask 122.60 x --
- Day's Range
118.60 - 124.60 - 52 Week Range
102.40 - 154.65 - Volume
1,381 - Avg. Volume
187,064 - Market Cap (intraday)
34.97B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
-- - EPS (TTM)
-0.16 - Earnings Date May 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 15, 2021
- 1y Target Est
--
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
www.ambu.comRecent News: 0MJF.IL
View MorePerformance Overview: 0MJF.IL
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0MJF.IL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0MJF.IL
View MoreValuation Measures
Market Cap
29.89B
Enterprise Value
29.86B
Trailing P/E
93.39
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.37
Price/Book (mrq)
5.19
Enterprise Value/Revenue
5.29
Enterprise Value/EBITDA
37.28
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.90%
Return on Assets (ttm)
1.80%
Return on Equity (ttm)
-0.88%
Revenue (ttm)
4.68B
Net Income Avi to Common (ttm)
-42M
Diluted EPS (ttm)
-0.16
Balance Sheet and Cash Flow
Total Cash (mrq)
144M
Total Debt/Equity (mrq)
14.20%
Levered Free Cash Flow (ttm)
-32M